| Predicate |
Object |
| assignee |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_0320630dedcefe5ebfb41cba943df202
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_6c221679cb5937799fa6495c839072c9
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_2e642ce2392ffdbf1e8e7d0266b7d96e |
| classificationCPCAdditional |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A23V2002-00 |
| classificationCPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07H13-08
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P3-04
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P3-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P43-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-7024
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A23F3-34
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A23F3-18
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A23F3-16
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A23L33-105 |
| classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A23L33-20
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D309-10
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-351
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A23L2-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P3-00 |
| filingDate |
2005-08-22-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_66a8b41670f3af3e8ca358b90f68f5eb
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_9abb5417544d073fd0f71d7c707cb73c
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_ea6e74728ce2dc09aea11c19049c5c31 |
| publicationDate |
2007-11-01-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber |
US-2007254948-A1 |
| titleOfInvention |
Lipase Inhibitors |
| abstract |
The present invention provides lipase inhibitory agents comprising a gallotannin or ellagitannin component(s) isolated from teas or Tellima grandiflora as well as foods and beverages and medicines containing said inhibitory agents. n nThe present invention provides lipase inhibitory agents comprising at least one of compounds represented by formula I below: n n nwherein R 1 , R 2 and R 3 independently represent H or a gallic acid residue, and R 4 and R 5 represent H or a gallic acid residue, or R 4 and R 5 together form an HHDP group represented by the formula below: n n nprovided that at least two of R 1 to R 5 represent a gallic acid residue or when all of R 1 , R 2 and R 3 are H, R 4 and R 5 together form the HHDP group; as well as foods and beverages and medicines containing said lipase inhibitory agents. |
| isCitedBy |
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-2009064082-A1 |
| priorityDate |
2004-08-23-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type |
http://data.epo.org/linked-data/def/patent/Publication |